BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17952972)

  • 1. [Coronary atherosclerosis].
    Ebina T; Kimura K
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():50-4. PubMed ID: 17952972
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivessel coronary artery disease: how do we treat it?
    Sharma S
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E15. PubMed ID: 18297143
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coronary artery disease in patients with diabetes mellitus and its treatment].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():94-9. PubMed ID: 11989270
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 6. Vulnerable plaque: scope of the problem.
    Wilensky RL
    J Interv Cardiol; 2008 Dec; 21(6):443-51. PubMed ID: 18973505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Unrecognized myocardial infarction].
    Matsumoto T
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():249-52. PubMed ID: 17952999
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute coronary syndrome].
    Nakagomi A; Kishida H
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():97-104. PubMed ID: 17948692
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis.
    Herman AG; Moncada S
    Eur Heart J; 2005 Oct; 26(19):1945-55. PubMed ID: 15911567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coronary atherosclerosis and vascular endothelial dysfunction].
    Nishinaga M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():75-9. PubMed ID: 12734956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy in the secondary prevention of atherosclerosis].
    Kettunen R
    Duodecim; 2002; 118(20):2093-101. PubMed ID: 12463000
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.
    Nayak D; Aronow WS
    Cardiol Rev; 2005; 13(2):95-7. PubMed ID: 15705260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of coronary artery disease.
    Hall SL; Lorenc T
    Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.
    Drozda J; Messer JV; Spertus J; Abramowitz B; Alexander K; Beam CT; Bonow RO; Burkiewicz JS; Crouch M; Goff DC; Hellman R; James T; King ML; Machado EA; Ortiz E; O'Toole M; Persell SD; Pines JM; Rybicki FJ; Sadwin LB; Sikkema JD; Smith PK; Torcson PJ; Wong JB; ; ; ; ; ; ; ; ;
    J Am Coll Cardiol; 2011 Jul; 58(3):316-36. PubMed ID: 21676572
    [No Abstract]   [Full Text] [Related]  

  • 17. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.
    Drozda J; Messer JV; Spertus J; Abramowitz B; Alexander K; Beam CT; Bonow RO; Burkiewicz JS; Crouch M; Goff DC; Hellman R; James T; King ML; Machado EA; Ortiz E; O'Toole M; Persell SD; Pines JM; Rybicki FJ; Sadwin LB; Sikkema JD; Smith PK; Torcson PJ; Wong JB
    Circulation; 2011 Jul; 124(2):248-70. PubMed ID: 21670226
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in diagnosis and treatment of acute coronary syndrome].
    Akita H; Yokoyama M
    Nihon Rinsho; 1998 Oct; 56(10):2471-6. PubMed ID: 9796304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerable plaque: definition, detection, treatment, and future implications.
    Ozer K; Cilingiroglu M
    Curr Atheroscler Rep; 2005 Mar; 7(2):121-6. PubMed ID: 15727727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choosing the right medication for the right patient].
    Durand E; Kadri Z; Danchin N
    Rev Prat; 2005 Oct; 55(16):1805-11. PubMed ID: 16363431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.